"Big IGF-II"-induced hypoglycemia secondary to gastric adenocarcinoma

Diabetes and Metabolism

Volumn 30, Issue 3 I, 2004, Pages 276-278

  Morbois Trabut, L ^a   Maillot, F ^a   De Widerspach Thor, A ^a   Lamisse, F ^a   Couet, C ^a  

^a CHU BRETONNEAU   (France)

Author keywords

"Big IGF II"; Gastric adenocarcinoma; Hypoglycaemia; IGF II; Insulin

Indexed keywords

INSULIN; OCTREOTIDE; PREDNISOLONE; SOMATOMEDIN B;

ADULT; ARTICLE; CAPILLARY FLOW; CARDIA; CASE REPORT; CELL DIFFERENTIATION; DISEASE SEVERITY; ENTERIC FEEDING; GLUCOSE BLOOD LEVEL; HEMIPARESIS; HOSPITAL ADMISSION; HUMAN; HYPOGLYCEMIA; MALE; METASTASIS; PANCREAS NON ISLET CELL TUMOR; PANCREAS TUMOR; PROTEIN DEFECT; RARE DISEASE; STOMACH ADENOCARCINOMA;

EID: 3142736329     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70119-2     Document Type: Article

References (11)

1. Elliot CA. Hepatic hypoglycemia associated with primary liver carcinoma. Transactions of the Association of American Physicians, 1929, 44, 121.
2. Vitally ML, Guillausseau PJ. Hypoglycemia in adults. Diabetes Metab, 1999, 477-90.
3. Zapf J, Futo E, Peter M, Froesch ER. Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia? J Clin Invest, 1992, 90, 2574-84.
4. Bond JJ, Meka S, Baxter RC. Binding characteristics of pro-insulin-like growth factor-II from cancer patients: binary and ternary complex formation with IGF binding proteins-1 to -6. J Endocrinol, 2000, 165, 253-60.
5. Zapf J. Role of insulin-like growth factor II and IGF binding proteins in extrapancreatic tumor hypoglycemia. Horm Res, 1994, 42, 20-6.
6. Hizuka N, Fukuda I, Takano K, Okubo Y, Asakawa-Yasumoto K, Demura H. Serum insulin-like growth factor II in 44 patients with non-islet cell tumor hypoglycemia, Endocr J, 1998, 45, S61-5.
7. Macdougall IC, Fleming S, Frier BM. Hypoglycaemic coma associated with gastric carcinoma. Postgrad Med J, 1986, 62, 761-4.
8. Perros P, Simpson J, Innes JA, Teale JD, McKnight JA. Non-islet cell tumour-associated hypoglycaemia: 111In-octreotide imaging and efficacy of octreotide, growth hormone and glucocorticosteroids. Clin Endocrinol (Oxf), 1996, 44, 727-31.
9. Foger B, Zapf J, Lechleitner M, Konwalinka G, Patsch JR. Prevention with glucocorticoids of extrapancreatic tumour-hypoglycaemia as a result of increased 'big' insulin-like growth factor II. J Intern Med, 1994, 236, 692-3.
10. Teale JD, Marks V. Glucocorticoid therapy suppresses abnormal secretion of big IGF-II by non-islet cell tumours inducing hypoglycaemia (NICTH). Clin Endocrinol (Oxf), 1998, 49, 491-8.
11. Seckl MJ, Mulholland PJ, Bishop AE, et al. Hypoglycemia due to an insulin-secreting small-cell carcinoma of the cervix. N Engl J Med, 1999, 341, 733-6.